Welcome to RealPharma!
RealPharma
RealPharma
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
Choose your favorite podcast player
RealPharma

RealPharma

For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare.

RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.

The player is loading ...
Where Policy Meets the Pharmacy Counter

Recent Episodes

Oct. 13, 2025

Where Policy Meets the Pharmacy Counter

Where Policy Meets the Pharmacy Counter Featuring Congressman Jake Auchincloss Episode Summary In this episode of RealPharma , hosts Na-Ri Oh and Ian Wendt sit down with Congressman Jake Auchincloss (MA-04) to dissect the tan...

Listen to the Episode
Oct. 6, 2025

Conversations, Not Campaigns: The Art of Authentic Engagement in Heal…

Episode Title: “Conversations, Not Campaigns: The Art of Authentic Engagement in Healthcare” 🗣️ Episode Summary In this episode, hosts Dr. Na-Ri Oh and Ian Wendt sit down with Colin Hung — healthcare technologist, marketing s...

Listen to the Episode
Sept. 22, 2025

Building the Highway for AI in Pharma: A Conversation with Ilya Burkov

🎙️ Episode Title: Building the Highway for AI in Pharma: A Conversation with Ilya Burkov 📍 Episode Summary In this episode of RealPharma , hosts Na-Ri Oh and Ian Wendt sit down with Dr. Ilya Burkov, Head of AI Cloud at Nebius...

Listen to the Episode
Sept. 8, 2025

Inside the CMC Black Box: A Deep Dive with Reza Oliyai

🎙️ Episode Title: Inside the CMC Black Box: A Deep Dive with Reza Oliyai 🧾 Show Notes: What exactly is CMC — and why is it behind more FDA rejections than any other category? In this episode of RealPharma , hosts Na-Ri Oh and...

Listen to the Episode
Aug. 25, 2025

Can We Say That? Dara Katcher Levy on the AdPromo Regulatory Landscape

In this episode of RealPharma, Ian Wendt and Na-Ri Oh sit down with Dara Katcher Levy, a regulatory attorney at Hyman, Phelps & McNamara, P.C. —widely regarded as one of the nation’s top firms in food and drug law. Dara bring...

Listen to the Episode
Aug. 11, 2025

From Rock Star to Rare Disease Revolutionary: Casey McPherson’s Fight…

Episode Title: From Rock Star to Rare Disease Revolutionary: Casey McPherson’s Fight for His Daughter’s Life In this deeply personal and inspiring conversation, hosts Na-Ri Oh and Ian Wendt sit down with Casey McPherson, foun...

Listen to the Episode

About the Hosts

Dr. Na-Ri Oh Profile Photo

Dr. Na-Ri Oh

As an innovative biopharmaceutical leader with a medical background in Infectious Diseases, Na-Ri Oh, MD brings a unique blend of clinical and business acumen to the table. Na-Ri has held a wide variety of commercial and strategy leadership roles in multiple pharmaceutical companies. Nari has over two decades of experience in clinical patient care and research as well as leading global marketing and strategic planning initiatives, particularly in the areas of HIV, viral hepatitis, and liver disease. Na-Ri is especially passionate about global public health and alternative commercialization models in emerging markets.

Ian Wendt Profile Photo

Ian Wendt

Ian Wendt has over three decades of experience in the biotechnology and pharmaceutical sectors. Ian is currently serving as the Chief Commercial Officer at an emerging biotechnology company. Prior to his current role, Ian has held leadership positions at a variety of large pharmaceutical companies leading national teams and driving market development outcomes in HIV treatment and prevention, and hepatitis C. His expertise spans business strategy, revenue and profit growth, and cross-functional leadership, making him a sought-after voice in the industry.